In the CNS injury models, the role of IL-17A is reported detrimental, which expression is induced by active microglia/macrophages-derived IL-23 at the secondary injury stage (19, 45), whereas IL-17A is also reported to benefit the survival and differentiation of neural precursor cells, and functional recovery of stroke at the delayed phases (46). Here, IL17A is linked to Stroke.